241 related articles for article (PubMed ID: 22932446)
21. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK
J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709
[TBL] [Abstract][Full Text] [Related]
22. Human embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis.
Vinarsky V; Krivanek J; Rankel L; Nahacka Z; Barta T; Jaros J; Andera L; Hampl A
Stem Cells Dev; 2013 Nov; 22(22):2964-74. PubMed ID: 23806100
[TBL] [Abstract][Full Text] [Related]
23. Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.
Aggarwal BB; Bhardwaj U; Takada Y
Vitam Horm; 2004; 67():453-83. PubMed ID: 15110190
[TBL] [Abstract][Full Text] [Related]
24. CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.
Travert M; Ame-Thomas P; Pangault C; Morizot A; Micheau O; Semana G; Lamy T; Fest T; Tarte K; Guillaudeux T
J Immunol; 2008 Jul; 181(2):1001-11. PubMed ID: 18606651
[TBL] [Abstract][Full Text] [Related]
25. Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells.
Han MA; Lee DH; Woo SM; Seo BR; Min KJ; Kim S; Park JW; Kim SH; Choi YH; Kwon TK
Sci Rep; 2016 Jan; 6():18642. PubMed ID: 26725939
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.
Harper N; Hughes MA; Farrow SN; Cohen GM; MacFarlane M
J Biol Chem; 2003 Nov; 278(45):44338-47. PubMed ID: 12920112
[TBL] [Abstract][Full Text] [Related]
27. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A
J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684
[TBL] [Abstract][Full Text] [Related]
28. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling.
Kreuz S; Siegmund D; Scheurich P; Wajant H
Mol Cell Biol; 2001 Jun; 21(12):3964-73. PubMed ID: 11359904
[TBL] [Abstract][Full Text] [Related]
29. Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation.
Bortul R; Tazzari PL; Cappellini A; Tabellini G; Billi AM; Bareggi R; Manzoli L; Cocco L; Martelli AM
Leukemia; 2003 Feb; 17(2):379-89. PubMed ID: 12592338
[TBL] [Abstract][Full Text] [Related]
30. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
31. Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis.
Higuchi H; Yoon JH; Grambihler A; Werneburg N; Bronk SF; Gores GJ
J Biol Chem; 2003 Jan; 278(1):454-61. PubMed ID: 12407100
[TBL] [Abstract][Full Text] [Related]
32. R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway.
Festa M; Petrella A; Alfano S; Parente L
Int J Cancer; 2009 Jun; 124(11):2728-36. PubMed ID: 19230027
[TBL] [Abstract][Full Text] [Related]
33. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
34. Differential responses of FLIPLong and FLIPShort-overexpressing human myeloid leukemia cells to TNF-alpha and TRAIL-initiated apoptotic signals.
Seal S; Hockenbery DM; Spaulding EY; Kiem HP; Abbassi N; Deeg HJ
Exp Hematol; 2008 Dec; 36(12):1660-72. PubMed ID: 18838202
[TBL] [Abstract][Full Text] [Related]
35. Accelerated degradation of cFLIP
Lee SR; Quan KT; Byun HS; Park I; Kang K; Piao X; Ju E; Ro H; Na M; Hur GM
Sci Rep; 2019 Sep; 9(1):13505. PubMed ID: 31534206
[TBL] [Abstract][Full Text] [Related]
36. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2.
Diessenbacher P; Hupe M; Sprick MR; Kerstan A; Geserick P; Haas TL; Wachter T; Neumann M; Walczak H; Silke J; Leverkus M
J Invest Dermatol; 2008 May; 128(5):1134-47. PubMed ID: 17989734
[TBL] [Abstract][Full Text] [Related]
37. Kurarinone Synergizes TRAIL-Induced Apoptosis in Gastric Cancer Cells.
Zhou W; Cao A; Wang L; Wu D
Cell Biochem Biophys; 2015 May; 72(1):241-9. PubMed ID: 25524636
[TBL] [Abstract][Full Text] [Related]
38. A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.
Dai Y; Liu M; Tang W; Li Y; Lian J; Lawrence TS; Xu L
BMC Cancer; 2009 Nov; 9():392. PubMed ID: 19895686
[TBL] [Abstract][Full Text] [Related]
39. cFLIPL prevents TRAIL-induced apoptosis of hepatocellular carcinoma cells by inhibiting the lysosomal pathway of apoptosis.
Guicciardi ME; Bronk SF; Werneburg NW; Gores GJ
Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1337-46. PubMed ID: 17272514
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin.
Jani TS; DeVecchio J; Mazumdar T; Agyeman A; Houghton JA
J Biol Chem; 2010 Jun; 285(25):19162-72. PubMed ID: 20424169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
